Has Shevonne Chude received payments from drug or device companies?

Yes. Drug and device makers reported $7,287 in general payments to Shevonne Chude across 279 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Shevonne Chude did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Shevonne Chude come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Shevonne Chude

Medical · Pikesville, MDNPI 1114273695

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $6,176 of the $7,287 with a category attached, or 84.8%. It is spread thinly across 22 manufacturers, the largest accounting for just 17.8% — the pattern of someone who eats at a lot of different presentations. Among medical clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,287in general payments, 2019–2025

Across 279 payments — averaging $26.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

LEO Pharma Inc.$1K
Johnson & Johnson$1K
AbbVie$833
Dermavant Sciences, Inc.$778
E.r. Squibb & Sons, L.L.C.$518
Sun Pharmaceutical Industries Inc.$430
plus $2K from 16 others

What the payments were for

Consulting fees$4106%
Food & beverage$6,17685%
Education$70110%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
LEO Pharma Inc.	14	$1,294
Johnson & Johnson	54	$1,026
AbbVie	41	$833
Dermavant Sciences, Inc.	31	$778
E.r. Squibb & Sons, L.L.C.	20	$518
Sun Pharmaceutical Industries Inc.	11	$430
Sanofi	12	$275
Galderma Laboratories, L.p.	10	$272
Incyte Corporation	14	$255
Regeneron Healthcare Solutions, Inc.	10	$233
UCB, Inc.	9	$224
Journey Medical Corporation	3	$177
Novartis	17	$174
Ortho Dermatologics, A Division Of Bausch Health US, LLC	7	$160
Amgen	6	$139
Arcutis Biotherapeutics, Inc.	4	$132
Verrica Pharmaceuticals Inc.	2	$96
Lilly USA, LLC	4	$85
Almirall LLC	3	$66
Pfizer	3	$49
Merz North America, Inc.	2	$43
Organon	2	$26

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ADBRY$1,010
VTAMA$507
Sotyktu$240
NEMLUVIO$150
ENSTILAR$140
Winlevi$122
Exelderm$121
QBREXZA$121
Rinvoq$120

How this compares

$7,287 in reported general payments places this provider in the 90th percentile of 543 medical providers in Maryland.

See all medical providers in Maryland →

Medicare billing

Part B allowed, 2024

$143,926

Medicare patients

759

Services billed

2,145

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Dupixent PenDupilumab	14	$54,305
Clobetasol Propionate	56	$2,261
Betamethasone Dipropionate	38	$1,619
Ciclopirox	39	$1,516
Tretinoin	20	$1,405
Halobetasol Propionate	19	$1,046
Metronidazole	12	$863
Triamcinolone Acetonide	108	$663
Fluocinonide	17	$595
Ketoconazole	44	$426
Econazole Nitrate	12	$423
ValacyclovirValacyclovir Hcl	14	$237
Doxycycline Hyclate	15	$228
Clindamycin Phosphate	11	$228
Mupirocin	22	$181

Paid to pharmacies, not to this prescriber.

Other medical in Pikesville

Victoria TrottStevensville$94K
Sarah SagorskyBaltimore$68K
Emily GrisnikLeonardtown$62K
Jennifer HamiltonBel Air$52K
Kristina TrunnellFrederick$51K
Karen ScottAnnapolis$49K
Nicholas WunderAberdeen$40K
Sarah JamiesonFrederick$34K
Jayme WilliamsCatonsville$21K
Megan PayneLutherville$19K

See the full list for Maryland →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →